Crestchem Limited (BOM:526269)
140.25
+3.80 (2.78%)
At close: Sep 11, 2026
Crestchem Market Cap
Crestchem has a market cap or net worth of 420.75 million as of September 11, 2026. Its market cap has increased by 4.04% in one year.
Market Cap
420.75M
Enterprise Value
416.95M
Revenue
338.33M
Ranking
n/a
PE Ratio
12.72
Stock Price
140.25
ChartMarket Cap Chart
Since November 1, 2012, Crestchem's market cap has increased from 31.23M to 420.75M, an increase of 1,247.26%. That is a compound annual growth rate of 20.63%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 420.75M | 24.72% |
| Dec 31, 2025 | 337.35M | -59.85% |
| Dec 31, 2024 | 840.15M | 239.45% |
| Dec 29, 2023 | 247.50M | 38.66% |
| Dec 30, 2022 | 178.50M | 35.69% |
| Dec 31, 2021 | 131.55M | -13.68% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Panchsheel Organics | 1.46B |
| Kimia Biosciences | 1.40B |
| Krebs Biochemicals & Industries | 1.33B |
| Tyche Industries | 1.15B |
| Vasundhara Rasayans | 461.47M |
| Alfavision Overseas (India) | 398.17M |
| Bacil Pharma | 264.96M |
| Ishita Drugs and Industries | 221.28M |